Mayra Guerrero

Summary

Affiliation: William Beaumont Hospital
Country: USA

Publications

  1. ncbi Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the primary angioplasty in myocardial infarction trials
    Mayra Guerrero
    William Beaumont Hospital, Royal Oak, Michigan, USA
    Am J Cardiol 96:482-8. 2005
  2. ncbi Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database)
    Mayra Guerrero
    William Beaumont Hospital, Royal Oak, Michigan, USA
    Am J Cardiol 96:649-54. 2005
  3. ncbi Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction
    Mayra Guerrero
    Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA
    J Interv Cardiol 21:242-51. 2008
  4. ncbi Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention
    Sandeep Khosla
    Section of Cardiology and Endovascular Therapeutics, Mount Sinai Hospital Chicago, IL 60608, USA
    Am J Ther 9:488-91. 2002

Collaborators

Detail Information

Publications4

  1. ncbi Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the primary angioplasty in myocardial infarction trials
    Mayra Guerrero
    William Beaumont Hospital, Royal Oak, Michigan, USA
    Am J Cardiol 96:482-8. 2005
    ..Because 85% of deaths in patients who have left BBB occur within the first week, these patients should be recognized early and receive prompt and aggressive treatment...
  2. ncbi Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database)
    Mayra Guerrero
    William Beaumont Hospital, Royal Oak, Michigan, USA
    Am J Cardiol 96:649-54. 2005
    ..032). In conclusion, patients with AMI with PVD have increased co-morbidities and higher mortality despite treatment with primary angioplasty. The presence of PVD is an independent predictor of in-hospital mortality and death at 1 year...
  3. ncbi Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction
    Mayra Guerrero
    Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA
    J Interv Cardiol 21:242-51. 2008
    ..It is unknown whether this effect is present in reperfused MI. We sought to investigate the effect of VEGF-165 gene therapy on cardiomyogenesis after reperfused MI...
  4. ncbi Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention
    Sandeep Khosla
    Section of Cardiology and Endovascular Therapeutics, Mount Sinai Hospital Chicago, IL 60608, USA
    Am J Ther 9:488-91. 2002
    ....